Abstract
Objective
The objective of this study was to systematically review patient-reported outcomes of long-term macrolide therapy, compared with any other treatment, for adults with chronic rhinosinusitis.
Data Sources
EMBASE and PubMed databases were searched in October 2011.
Review Methods
A total of 1216 citations were screened initially by a single author, 23 full-text manuscripts were evaluated by 2 authors using structured data abstraction forms to assess for inclusion criteria and study quality, and 3 studies were included in the final review.
Results
This review finds that 3 prospective clinical studies have evaluated the effect of macrolide therapy for chronic rhinosinusitis. Based on the limited data, there is limited scientific evidence to support the use of long-term macrolide therapy for chronic rhinosinusitis.
Conclusion
Further clinical research is needed to determine whether there may be a subgroup effect based on the underlying inflammatory disease process.
Get full access to this article
View all access options for this article.